Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of freeze-dried human rabies vaccine (MRC-5 cells) with 4-dose and 5-dose regimens
ChiCTR2400079724Phase 3Completed
- Sponsor
- Hunan Provincial Center for Disease Control and Prevention
- Start
- Jan 2024
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of Rabies vaccine (MRC-5 cells) in rabies (3 arms), sponsored by Hunan Provincial Center for Disease Control and Prevention. Primary endpoints: Antibody positive conversion rate, Geometric mean concentration of antibodies and 4 more. Started Jan 2024; status: completed.
02
Drugs
Rabies vaccine (MRC-5 cells)
03
Conditions
rabies
Beyond the preview
Go deeper on ChiCTR2400079724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079724.